Search research articles
Contact Us
Filters
Showing results (61-70 of 132) with videos related to
Page
of 14
Sort By:
World Journal of Urology
|
January 26, 2021
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
Fahad Quhal, Benjamin Pradere, Ekaterina Laukhtina, et al.
Nature Reviews. Urology
|
December 24, 2021
The placebo and nocebo effects in functional urology
Hadi Mostafaei, Sandra Jilch, Greta Lisa Carlin, et al.
European Urology Oncology
|
January 7, 2022
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy
Ekaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
International Urogynecology Journal
|
November 12, 2021
Clinical application of stem cell therapy in neurogenic bladder: a systematic review and meta-analysis
Hanieh Salehi-Pourmehr, Ozra Nouri, Amirreza Naseri, et al.
Urologic Oncology
|
August 11, 2020
Primary Ta high grade bladder tumors: Determination of the risk of progression
Fahad Quhal, David D'Andrea, Francesco Soria, et al.
European Urology Focus
|
May 13, 2022
Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma
Ekaterina Laukhtina, Melanie R Hassler, Benjamin Pradere, et al.
International Immunopharmacology
|
March 27, 2022
The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: A systematic review and meta-analysis
Keiichiro Mori, Fahad Quhal, Takafumi Yanagisawa, et al.
Urologic Oncology
|
March 5, 2020
Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy
Keiichiro Mori, Florian Janisch, Hadi Mostafaei, et al.
Urologic Oncology
|
August 15, 2022
Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis
Takafumi Yanagisawa, Tatsushi Kawada, Pawel Rajwa, et al.
Urologic Oncology
|
May 13, 2022
Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis
Takafumi Yanagisawa, Keiichiro Mori, Tatsushi Kawada, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 132) with videos related to
Sort By:
Page
of 14
World Journal of Urology
|
January 26, 2021
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
Fahad Quhal, Benjamin Pradere, Ekaterina Laukhtina, et al.
Nature Reviews. Urology
|
December 24, 2021
The placebo and nocebo effects in functional urology
Hadi Mostafaei, Sandra Jilch, Greta Lisa Carlin, et al.
European Urology Oncology
|
January 7, 2022
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy
Ekaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
International Urogynecology Journal
|
November 12, 2021
Clinical application of stem cell therapy in neurogenic bladder: a systematic review and meta-analysis
Hanieh Salehi-Pourmehr, Ozra Nouri, Amirreza Naseri, et al.
Urologic Oncology
|
August 11, 2020
Primary Ta high grade bladder tumors: Determination of the risk of progression
Fahad Quhal, David D'Andrea, Francesco Soria, et al.
European Urology Focus
|
May 13, 2022
Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma
Ekaterina Laukhtina, Melanie R Hassler, Benjamin Pradere, et al.
International Immunopharmacology
|
March 27, 2022
The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: A systematic review and meta-analysis
Keiichiro Mori, Fahad Quhal, Takafumi Yanagisawa, et al.
Urologic Oncology
|
March 5, 2020
Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy
Keiichiro Mori, Florian Janisch, Hadi Mostafaei, et al.
Urologic Oncology
|
August 15, 2022
Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis
Takafumi Yanagisawa, Tatsushi Kawada, Pawel Rajwa, et al.
Urologic Oncology
|
May 13, 2022
Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis
Takafumi Yanagisawa, Keiichiro Mori, Tatsushi Kawada, et al.
Page
of 14